See more : Medivolve Inc. (MEDVF) Income Statement Analysis – Financial Results
Complete financial analysis of First Real Estate Investment Trust (AW9U.SI) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of First Real Estate Investment Trust, a leading company in the REIT – Healthcare Facilities industry within the Real Estate sector.
- Wood One Co.,Ltd. (7898.T) Income Statement Analysis – Financial Results
- Wee Hur Holdings Ltd. (E3B.SI) Income Statement Analysis – Financial Results
- Ocean Spray Cranberries, Inc. PFD 4% (OCESP) Income Statement Analysis – Financial Results
- Axcella Health Inc. (AXLA) Income Statement Analysis – Financial Results
- Selic Corp Public Company Limited (SELIC.BK) Income Statement Analysis – Financial Results
First Real Estate Investment Trust (AW9U.SI)
About First Real Estate Investment Trust
First Real Estate Investment Trust ("First REIT") is a real estate investment trust constituted by the Trust Deed entered into on 19 October 2006 between First REIT Management Limited (formerly Bowsprit Capital Corporation Limited) as the Manager and HSBC Institutional Trust Services (Singapore) Limited as the Trustee. First REIT was listed on the Singapore Exchange Securities Trading Limited on 11 December 2006. On 1 March 2018, HSBC Institutional Trust Services (Singapore) Limited retired as the Trustee of First REIT in favour of Perpetual (Asia) Limited. First REIT is Singapore's first healthcare real estate investment trust that aims to invest in a diversified portfolio of income-producing real estate and / or real estate-related assets in Asia that are primarily used for healthcare and / or healthcare-related purposes. Managed by First REIT Management Limited,, First REIT's portfolio consists of 20 properties located in Indonesia, Singapore and South Korea, namely 1) Siloam Hospitals Lippo Village, 2) Siloam Hospitals Kebon Jeruk, 3) Siloam Hospitals Surabaya, 4) Imperial Aryaduta Hotel & Country Club, 5) Mochtar Riady Comprehensive Cancer Centre, 6) Siloam Hospitals Lippo Cikarang, 7) Siloam Hospitals Manado & Hotel Aryaduta Manado, 8) Siloam Hospitals Makassar, 9) Siloam Hospitals Bali, 10) Siloam Hospitals TB Simatupang, 11) Siloam Hospitals Purwakarta, 12) Siloam Sriwijaya, 13) Siloam Hospitals Kupang & Lippo Plaza Kupang, 14) Siloam Hospitals Labuan Bajo, 15) Siloam Hospitals Buton & Lippo Plaza Buton, 16) Siloam Hospitals Yogyakarta, 17) Pacific Healthcare Nursing Home @ Bukit Merah, 18) Pacific Healthcare Nursing Home II @ Bukit Panjang, 19) The Lentor Residence and 20) Sarang Hospital. Its hospital assets in Indonesia are operated by PT Siloam International Hospitals Tbk, a subsidiary of PT Lippo Karawaci Tbk, a strong brand name in the Indonesian healthcare industry supported by a team of international healthcare professionals whereas The Imperial Aryaduta Hotel & Country Club and Hotel Aryaduta Manado are operated by The Aryaduta Hotel and Resort Group. The Lippo Plaza Kupang and Lippo Plaza Buton are managed by PT Lippo Malls Indonesia. In Singapore, the nursing homes at Bukit Merah and Bukit Panjang are operated by Pacific Healthcare Nursing Home Pte. Ltd. and Pacific Eldercare and Nursing Pte. Ltd., respectively. The Lentor Residence is operated by The Lentor Residence Pte. Ltd. In South Korea, the Sarang Hospital is operated by a private doctor. Through First REIT, investors can participate in an asset class that has a focus towards Asia's growing healthcare sector, which is boosted by an increase in life expectancy in Indonesia and the rest of Southeast Asia.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 108.57M | 111.28M | 102.35M | 79.62M | 115.30M | 116.20M | 110.99M | 107.02M | 100.70M | 93.26M | 83.28M | 57.65M | 54.01M | 30.27M | 29.85M | 30.18M | 28.29M |
Cost of Revenue | 13.32M | 3.09M | 2.44M | 2.57M | 2.83M | 2.23M | 1.92M | 1.58M | 1.79M | 1.72M | 3.37M | 614.00K | 570.00K | -62.00K | 62.00K | 214.00K | 237.00K |
Gross Profit | 95.25M | 108.18M | 99.91M | 77.05M | 112.46M | 113.96M | 109.07M | 105.44M | 98.90M | 91.53M | 79.91M | 57.03M | 53.44M | 30.34M | 29.79M | 29.96M | 28.05M |
Gross Profit Ratio | 87.73% | 97.22% | 97.61% | 96.77% | 97.54% | 98.08% | 98.27% | 98.52% | 98.22% | 98.15% | 95.95% | 98.93% | 98.94% | 100.20% | 99.79% | 99.29% | 99.16% |
Research & Development | 0.00 | 0.47 | 0.72 | -4.42 | 0.64 | 0.64 | 0.83 | 0.59 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 361.00K | 11.07M | 9.88M | 9.87M | 11.79M | 11.86M | 11.82M | 10.97M | 10.19M | 9.51M | 8.22M | 5.92M | 5.44M | 356.00K | 2.94M | 3.05M | 2.78M |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 361.00K | 11.07M | 9.88M | 9.87M | 11.79M | 11.86M | 11.82M | 10.97M | 10.19M | 9.51M | 8.22M | 5.92M | 5.44M | 356.00K | 2.94M | 3.05M | 2.78M |
Other Expenses | 0.00 | -979.00K | -1.48M | -5.25M | -781.00K | -825.00K | -1.24M | -2.59M | -1.08M | -806.00K | -452.00K | -423.00K | -218.00K | -969.00K | 26.68M | -700.00K | 90.95M |
Operating Expenses | 361.00K | 11.09M | 9.88M | 9.87M | 11.79M | 11.86M | 11.82M | 10.97M | 10.19M | 9.51M | 8.22M | 5.92M | 7.14M | 3.62M | 3.22M | 3.65M | 3.27M |
Cost & Expenses | 13.68M | 14.18M | 12.32M | 12.44M | 14.62M | 14.09M | 13.75M | 12.55M | 11.99M | 11.23M | 11.59M | 6.53M | 7.71M | 3.56M | 3.22M | 3.87M | 3.51M |
Interest Income | -4.17M | 277.00K | 146.00K | 1.44M | 2.36M | 1.69M | 1.43M | 1.13M | 231.00K | 199.00K | 163.00K | 132.00K | 104.00K | 26.00K | 43.00K | 214.00K | 0.00 |
Interest Expense | 18.02M | 14.07M | 11.82M | 14.71M | 17.49M | 16.50M | 15.73M | 16.08M | 15.10M | 13.38M | 11.13M | 3.82M | 3.78M | 2.23M | 1.98M | 1.85M | 0.00 |
Depreciation & Amortization | 13.00K | 14.00K | 13.00K | 14.00K | 13.00K | 161.14K | 52.52K | -13.41M | 20.00M | 43.47M | 58.40M | 30.23M | 0.00 | 55.47M | 215.00K | 140.00K | -304.00K |
EBITDA | 96.25M | 67.20M | 83.34M | 57.88M | 93.93M | 91.28M | 109.29M | 80.32M | 109.25M | 126.06M | 130.50M | 81.76M | 64.39M | 82.22M | 26.85M | 26.24M | 25.09M |
EBITDA Ratio | 88.66% | 60.39% | 81.43% | -428.43% | 81.47% | 78.70% | 98.97% | 77.16% | 108.49% | 135.18% | 156.70% | 141.82% | 119.23% | 271.58% | 89.95% | 87.65% | 87.60% |
Operating Income | 94.89M | 67.19M | 83.33M | -341.13M | 93.92M | 91.45M | 109.85M | 95.98M | 89.25M | 82.59M | 72.10M | 51.53M | 64.39M | 26.74M | 26.64M | 24.46M | 23.17M |
Operating Income Ratio | 87.40% | 60.38% | 81.42% | -428.45% | 81.46% | 78.70% | 98.97% | 89.69% | 88.64% | 88.57% | 86.57% | 89.39% | 119.23% | 88.34% | 89.23% | 81.06% | 81.91% |
Total Other Income/Expenses | -16.67M | -45.85M | -14.99M | -425.42M | -25.29M | -27.33M | -3.69M | -30.61M | 7.25M | 30.29M | 47.43M | 31.41M | 16.72M | 55.83M | 14.04M | -700.00K | 90.95M |
Income Before Tax | 78.22M | 51.95M | 75.81M | -358.23M | 75.39M | 74.78M | 93.56M | 64.25M | 96.28M | 112.69M | 119.36M | 77.94M | 60.62M | 79.99M | 38.68M | 23.76M | 114.13M |
Income Before Tax Ratio | 72.04% | 46.69% | 74.07% | -449.93% | 65.39% | 64.35% | 84.29% | 60.03% | 95.61% | 120.84% | 143.33% | 135.20% | 112.24% | 264.21% | 129.56% | 78.74% | 403.41% |
Income Tax Expense | 14.88M | 18.37M | 12.70M | -5.82M | 26.47M | -1.10M | 20.12M | 23.91M | 28.50M | 22.08M | 1.53M | 12.69M | 9.66M | 19.53M | 2.71M | 809.00K | 31.69M |
Net Income | 63.34M | 33.59M | 63.11M | -352.41M | 48.92M | 75.88M | 73.44M | 40.34M | 67.78M | 90.60M | 117.83M | 65.24M | 50.95M | 69.50M | 35.96M | 22.95M | 82.44M |
Net Income Ratio | 58.34% | 30.18% | 61.67% | -442.62% | 42.43% | 65.30% | 66.16% | 37.70% | 67.31% | 97.16% | 141.49% | 113.18% | 94.34% | 229.57% | 120.48% | 76.06% | 291.40% |
EPS | 0.03 | 0.02 | 0.04 | -0.40 | 0.05 | 0.09 | 0.08 | 0.05 | 0.08 | 0.11 | 0.15 | 0.09 | 0.07 | 0.16 | 0.09 | 0.06 | 0.20 |
EPS Diluted | 0.03 | 0.02 | 0.04 | -0.40 | 0.05 | 0.09 | 0.08 | 0.05 | 0.08 | 0.11 | 0.15 | 0.09 | 0.07 | 0.16 | 0.09 | 0.06 | 0.20 |
Weighted Avg Shares Out | 2.07B | 1.98B | 1.50B | 882.90M | 872.71M | 863.85M | 854.40M | 844.66M | 819.42M | 791.46M | 762.79M | 699.19M | 689.81M | 423.72M | 421.45M | 413.05M | 411.33M |
Weighted Avg Shares Out (Dil) | 2.07B | 1.98B | 1.50B | 882.90M | 872.71M | 863.85M | 857.95M | 844.66M | 819.42M | 791.46M | 762.79M | 699.19M | 689.81M | 423.72M | 421.45M | 413.05M | 411.33M |
Source: https://incomestatements.info
Category: Stock Reports